首页> 外文期刊>Expert opinion on biological therapy >Effectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugs
【24h】

Effectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugs

机译:系统性疫苗接种计划对用抗TNFα药物治疗的自身免疫性炎性疾病患者的有效性

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The objective of this is manuscript is to evaluate the impact of a vaccination protocol in the prevention of infection in autoimmune inflammatory disease (AUTID) patients treated with Anti-TNF-alpha therapies.Research design and methods: The authors conducted an observational study to test the effect of a vaccination program in AUTID patients that received anti-TNF-alpha therapies in hospital admissions related to infections. This effect was evaluated by comparing patients admitted before the program started (prevaccination period, 2009-2011) and after the program (postvaccination period, 2011-2014).Results: The study included 581 patients: 280 in the pre-vaccination group and 301 in the post-vaccination group. During the prevaccination period, 27.3% of patients treated with anti-TNF-alpha drugs were vaccinated before biological therapy. During the postvaccination period, this percentage increased to 97.0%. Statistically significant differences were detected in emergency room visits per 10.000 treatment days, in hospital admissions related to an infectious disease and in the rate of invasive pneumococcal disease due to Streptococcus pneumoniae infection per 10.000 days of treatment.Conclusions: This vaccination program decreases infectious complications and was associated with a lower amount of hospital admissions due to infections, emergency room visits and the rate of invasive pneumococcal disease.
机译:目的:本文的目的是评估接种疫苗方案对用抗TNF-α疗法治疗的自身免疫性炎性疾病(AUTID)患者的感染预防的影响。研究设计和方法:作者进行了一项观察性研究在接受与感染有关的医院入院接受抗TNF-α治疗的AUTID患者中测试疫苗接种计划的效果。通过比较该计划开始之前(疫苗接种前期,2009-2011)和该计划之后(疫苗接种后期,2011-2014)的入院患者的疗效,结果:该研究包括581例患者:接种前组280例和301例疫苗接种后组。在预疫苗接种期间,接受抗TNF-α药物治疗的患者中有27.3%在进行生物治疗之前已进行了疫苗接种。在疫苗接种后期间,该百分比增加到97.0%。在每10.000个治疗日的急诊室就诊次数,与感染性疾病相关的医院入院率和每10.000天的治疗中由于肺炎链球菌感染导致的侵袭性肺炎球菌病发生率方面,存在统计学上的显着差异。结论:此疫苗接种计划减少了感染并发症和与感染,急诊就诊和侵袭性肺炎球菌疾病的发生率相关的住院人数减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号